Your browser doesn't support javascript.
loading
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.
Johnson, Skyler Bryce; Soulos, Pamela R; Shafman, Timothy D; Mantz, Constantine A; Dosoretz, Arie P; Ross, Rudi; Finkelstein, Steven E; Collins, Sean P; Suy, Simeng; Brower, Jeffrey V; Ritter, Mark A; King, Christopher R; Kupelian, Patrick A; Horwitz, Eric M; Pollack, Alan; Abramowitz, Matthew C; Hallman, Mark A; Faria, Sergio; Gross, Cary P; Yu, James B.
Afiliación
  • Johnson SB; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, United States.
  • Soulos PR; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, United States.
  • Shafman TD; 21st Century Oncology, Fort Myers, United States.
  • Mantz CA; 21st Century Oncology, Fort Myers, United States.
  • Dosoretz AP; 21st Century Oncology, Fort Myers, United States.
  • Ross R; 21st Century Oncology, Fort Myers, United States.
  • Finkelstein SE; 21st Century Oncology, Fort Myers, United States.
  • Collins SP; Georgetown University Hospital, Washington, United States.
  • Suy S; Georgetown University Hospital, Washington, United States.
  • Brower JV; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States.
  • Ritter MA; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States.
  • King CR; University of California, Los Angeles-David Geffen School of Medicine, United States.
  • Kupelian PA; University of California, Los Angeles-David Geffen School of Medicine, United States.
  • Horwitz EM; Fox Chase Cancer Center, Philadelphia, United States.
  • Pollack A; Department of Radiation Oncology, Miller School of Medicine, University of Miami, United States.
  • Abramowitz MC; Department of Radiation Oncology, Miller School of Medicine, University of Miami, United States.
  • Hallman MA; Fox Chase Cancer Center, Philadelphia, United States.
  • Faria S; McGill University Health Center, Montreal, Canada.
  • Gross CP; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, United States.
  • Yu JB; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, United States; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, United States. Electronic address: james.b.yu@yale.edu.
Radiother Oncol ; 121(2): 294-298, 2016 11.
Article en En | MEDLINE | ID: mdl-27890426
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calidad de Vida / Radiocirugia Tipo de estudio: Clinical_trials / Etiology_studies / Systematic_reviews Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calidad de Vida / Radiocirugia Tipo de estudio: Clinical_trials / Etiology_studies / Systematic_reviews Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos